Skip to main content

Table 2 Patient factors examined by race.

From: Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for Black women after breast cancer treatment

 

Black

Others

p

Mean (Median) Age (yrs), all patients

54.2 (53.4)

53.6 (51.1)

.70

Mean (Median) Age (yrs), invasive disease

54.0 (53.4)

52.9 (51.2)

.55

% of patients ≤ 50 Y

41% (62/150)

50% (57/115)

.18

Mean (Median) BMI, all patients

31.6 (30.7)

29.2 (27.9)

<.05

Mean (Median) BMI, patients ≤ 45 Y

30.6 (30.6)

29.7 (29.2)

.60

Mean (Median) BMI, patients > 45 Y

32.0 (30.8)

28.9 (27.5)

<.01

Medical Comorbidities (≥ 1)

82/150 (55%)

48/115 (42%)

<.05

Medical Comorbidities (≥ 2)

34/150 (23%)

11/115 (10%)

<.01

Hypertension

69/150 (46%)

35/115 (30%)

<.05

Diabetes

15/150 (10%)

15/115 (13%)

.44

Cardiac disease or PVD

18/150 (12%)

6/115 (5%)

.06

Renal insufficiency

4/150 (3%)

1/115 (1%)

.29

Hepatitis and/or cirrhosis

6/150 (4%)

1/115 (1%)

.12

Reactive airway disease/COPD

15/150 (10%)

6/115 (5%)

.15

Contralateral Breast Cancer, all

8/150 (5%)

7/115 (6%)

.79

Contralateral Breast Cancer, synchronous

1/150 (1%)

5/115 (4%)

<.05

Contralateral Breast Cancer, metachronous

7/150 (5%)

2/115 (2%)

.19

Family History of Breast Cancer, any

41/150 (27%)

25/115 (22%)

.21

Family History of Breast Cancer, 1° relatives

15/41 (37%)

10/25 (40%)

.92

Health insurance, Uninsured

52/150 (35%)

66/115 (57%)

<.001*

Health insurance, Medicaid

38/150 (25%)

19/115 (17%)

 

Health insurance, Medicare

46/150 (31%)

15/115 (13%)

<.05#

Health insurance, Private

14/150 (9%)

15/115 (13%)

 

Screening Detected, all patients

55/150 (37%)

48/115 (42%)

.40

Screening Detected, invasive disease only

36/124 (29%)

31/91 (34%)

.43

  1. * Comparison of fraction of uninsured patients in each group.
  2. # Comparison of fraction of patients who were uninsured or had Medicaid vs. those who had Medicare and/or private insurance in each group.